Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionIMA Wealth, Inc.
Latest Disclosed Ownership2,132 shares
Latest Disclosed Value $ 1,647,268
IMA Wealth, Inc. reports 0.74% decrease in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On May 6, 2026 - IMA Wealth, Inc. filed a 13F-HR form disclosing ownership of 2,132 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $1,647,268 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 2,148 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -0.74% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F Regeneron Pharmaceuticals Common Stock 75886F107 2,132 -16 -0.74 1,647 -0.60 0.1608
2026-02-11 2025-12-31 13F Regeneron Pharmaceuticals Common Stock 75886F107 2,148 -23 -1.06 1,658 35.82 0.1592
2025-11-06 2025-09-30 13F Regeneron Pharmaceuticals Common Stock 75886F107 2,171 -31 -1.41 1,221 5.54 0.1230
2025-08-08 2025-06-30 13F Regeneron Pharmaceuticals Common Stock 75886F107 2,202 199 9.94 1,156 -8.98 0.1239
2025-05-06 2025-03-31 13F Regeneron Pharmaceuticals Common Stock 75886F107 2,003 -299 -12.99 1,270 -22.51 0.1507
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,302 -23 -0.99 1,640 -32.94 0.1974
2024-11-14 2024-09-30 13F Regeneron Pharmaceuticals Common Stock 75886F107 2,325 -392 -14.43 2,444 -14.40 0.5320
2024-08-06 2024-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 2,717 -60 -2.16 2,856 6.85 1.2613
2024-07-25 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,717 -60 2,856 0.6490
2024-04-24 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,777 -190 -6.40 2,673 2.57 1.2638
2024-02-05 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,967 -320 -9.74 2,606 -3.70 1.3045
2023-11-28 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,287 -44 -1.32 2,705 13.04 0.6990
2023-08-15 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,331 22 0.66 2,393 -11.96 0.6149
2023-05-16 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,309 -205 -5.83 2,719 7.22 0.7012
2023-02-16 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,514 -120 -3.30 2,535 1.28 0.6712
2022-11-15 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,634 -292 -7.44 2,503 7.84 0.6724
2022-08-18 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,926 -303 -7.16 2,321 -21.43 0.5680
2022-06-13 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,229 -122 -2.80 2,954 7.50 0.6780
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,351 -255 -5.54 2,748 -1.40 0.6068
2021-11-03 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,606 373 8.81 2,787 17.89 0.6584
2021-08-13 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,233 956 29.17 2,364 52.52 0.5524
2021-05-13 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,277 230 7.55 1,550 5.30 0.3797
2021-02-08 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,047 -396 -11.50 1,472 -23.61 0.4127
2020-11-16 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,443 1 0.03 1,927 -10.25 0.6461
2020-08-13 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,442 -26 -0.75 2,147 26.82 0.7763
2020-04-14 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,468 -2,497 -41.86 1,693 -24.42 0.7451
2020-02-24 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,965 -399 -6.27 2,240 26.91 0.8314
2019-10-29 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,364 -1,426 -18.31 1,765 -27.60 0.6666
2019-07-19 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,790 -67 -0.85 2,438 -24.43 0.9115
2019-05-09 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 7,857 1,251 18.94 3,226 30.77 1.2523
2019-01-15 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,606 -1,332 -16.78 2,467 -23.07 1.1510
2018-10-18 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,938 864 12.21 3,207 31.43 1.2541
2018-08-01 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,074 71 1.01 2,440 1.16 1.0166
2018-04-20 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 7,003 -24 -0.34 2,412 -8.71 1.0736
2018-02-05 2017-12-31 13F REGENERON PHARMACEUTICAL COM 75886F107 7,027 1,724 32.51 2,642 11.43 1.1820
2017-10-24 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,303 -532 -9.12 2,371 -17.27 1.1001
2017-07-31 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,835 -621 -9.62 2,866 14.55 1.3784
2017-06-06 2017-03-31 13F REGENERON PHARMACEUTICAL COM 75886F107 6,456 -757 -10.49 2,502 -5.51 1.2591
2017-03-30 2016-12-31 13F Regeneron Pharmaceuticals COM 75886F107 7,213 -560 -7.20 2,648 -15.26 1.6313
2016-12-07 2016-09-30 13F Regeneron Pharmaceuticals COM 75886F107 7,773 276 3.68 3,125 21.31 1.7864
2016-12-08 2016-06-30 13F Regeneron Pharmaceuticals COM 75886F107 7,497 -1,230 -14.09 2,576 -16.96 1.6161
2016-12-08 2016-03-31 13F Regeneron Pharmaceuticals COM 75886F107 8,727 205 2.41 3,102 -30.76 1.7993
2016-12-08 2015-12-31 13F Regeneron Pharmaceuticals COM 75886F107 8,522 39 0.46 4,480 18.46 2.7197
2016-12-08 2015-09-30 13F Regeneron Pharmaceuticals COM 75886F107 8,483 -62 -0.73 3,782 -13.24 2.3970
2015-07-24 2015-06-30 13F Regeneron Pharmaceuticals COM 75886F107 8,545 -75 -0.87 4,359 12.00 2.0736
2015-04-14 2015-03-31 13F Regeneron Pharmaceuticals COM 75886F107 8,620 280 3.36 3,892 13.77 1.8919
2015-01-09 2014-12-31 13F Regeneron Pharmaceuticals COM 75886F107 8,340 -75 -0.89 3,421 12.76 1.7675
2014-10-16 2014-09-30 13F Regeneron Pharmaceuticals COM 75886F107 8,415 275 3.38 3,034 31.97 1.4321
2014-07-17 2014-06-30 13F Regeneron Pharmaceuticals COM 75886F107 8,140 640 8.53 2,299 2.09 1.0519
2014-04-15 2014-03-31 13F Regeneron Pharmaceuticals COM 75886F107 7,500 620 9.01 2,252 18.90 1.0526
2014-01-30 2013-12-31 13F Regeneron Pharmaceuticals COM 75886F107 6,880 150 2.23 1,894 -10.07 0.9009
2013-10-03 2013-09-30 13F Regeneron Pharmaceuticals COM 75886F107 6,730 4,422 191.59 2,106 305.78 1.0334
2013-07-16 2013-06-30 13F Regeneron Pharmaceuticals COM 75886F107 2,308 2,308 519 0.2819
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.